Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Y CenY-H Liu

Abstract

Since December 2019, the novel coronavirus disease 2019 (COVID-19) that emerged in Wuhan city has spread rapidly around the world. The risk for poor outcome dramatically increases once a patient progresses to the severe or critical stage. The present study aims to investigate the risk factors for disease progression in individuals with mild to moderate COVID-19. We conducted a cohort study that included 1007 individuals with mild to moderate COVID-19 from three hospitals in Wuhan. Clinical characteristics and baseline laboratory findings were collected. Patients were followed up for 28 days for observation of disease progression. The end point was the progression to a more severe disease stage. During a follow up of 28 days, 720 patients (71.50%) had recovered or were symptomatically stable, 222 patients (22.05%) had progressed to severe disease, 22 patients (2.18%) had progressed to the critically ill stage and 43 patients (4.27%) had died. Multivariate Cox proportional hazards models identified that increased age (hazard ratio (HR) 2.56, 95% CI 1.97-3.33), male sex (HR 1.79, 95% CI 1.41-2.28), presence of hypertension (HR 1.44, 95% CI 1.11-1.88), diabetes (HR 1.82, 95% CI 1.35-2.44), chronic obstructive pulmonary disease (HR ...Continue Reading

References

Apr 4, 2006·Current Opinion in Pharmacology·Keiji KubaJosef M Penninger
Feb 9, 2010·PLoS Pathogens·Saskia L SmitsBart L Haagmans
Apr 27, 2012·International Journal of Peptides·Chris Tikellis, M C Thomas
Oct 8, 2013·Frontiers in Microbiology·Daisuke KuraiHajime Takizawa
Mar 22, 2015·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Yi-Ming YuanChuan Luo
May 20, 2016·Pathogens and Global Health·Hygor TrombettaSonia M Raboni
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leen J M SeysGuy G Brusselle
Mar 9, 2019·Expert Opinion on Drug Discovery·Allison L Totura, Sina Bavari
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 21, 2020·European Journal of Internal Medicine·Giuseppe Lippi, Brandon Michael Henry

❮ Previous
Next ❯

Citations

Sep 24, 2020·Reviews in Medical Virology·Sakthivel SuganyaMadasamy Parani
Aug 21, 2020·European Journal of Epidemiology·Petek Eylul TaneriTaulant Muka
Jul 19, 2020·Journal of Clinical Medicine·Matteo Nicola Dario Di MinnoPasquale Ambrosino
Sep 13, 2020·Journal of Community Health·Farha Musharrat Noor, Md Momin Islam
Aug 5, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Kenneth Jordan Ng Cheong Chung, Vijay Kunadian
Oct 10, 2020·Journal of Medical Internet Research·Pan PanLixin Xie
Nov 26, 2020·Hormones : International Journal of Endocrinology and Metabolism·Xuan LiangHaiyan Yang
Dec 30, 2020·Journal of Clinical Laboratory Analysis·Haoming ZhuBin Pei
Mar 2, 2021·Tobacco Use Insights·Chadia HaddadPascale Salameh
Feb 27, 2021·Medicina clínica·Chendi LiangGang Qin
Mar 12, 2021·Frontiers in Physiology·Simon B GressensEmmanuelle Vidal-Petiot
Feb 5, 2021·The Pediatric Infectious Disease Journal·Kelly GraffLisa Abuogi
Mar 13, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Citrawati Dyah Kencono Wungu Soetjipto
Mar 25, 2021·EClinicalMedicine·Firoozeh V GerayeliDon D Sin
Mar 30, 2021·Clinical Epidemiology and Global Health·Roshan Kumar MahatSumesh Prasad Sah
Apr 7, 2021·Journal of Diabetes and Metabolic Disorders·Sumanta SahaSujata Saha
Apr 11, 2021·Expert Review of Medical Devices·Maria Tsikala VafeaEleftherios Mylonakis
Feb 16, 2021·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Rahul ChaudharyRobert D McBane
Jun 11, 2021·Medicina Clínica·Chendi LiangGang Qin
Jul 9, 2021·International Journal of General Medicine·Lanqin LiuWenjun Liu
Jul 31, 2021·Journal of Multidisciplinary Healthcare·Faroque Md MohsinMohammad Delwer Hossain Hawlader
Aug 12, 2021·Current Pharmacology Reports·Omeed DarweeshNohad AlOmari
Aug 24, 2021·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Mercedes García-GasallaJavier Murillas
Oct 20, 2021·PLoS Neglected Tropical Diseases·Anahi Chechia do CoutoAlexander Welker Biondo

❮ Previous
Next ❯

Software Mentioned

R
R Foundation for Statistical Computing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.